Clinical Research
Please contact your provider to learn if you are eligible for any of our enrolling clinical trials.
Benefits to participants
- Learn more about your condition
- Get free study-related eye examinations, when appropriate
- Help others by assisting researchers to find better and more effective treatments
- Receive possible financial compensation for your time
Age-Related Macular Degeneration
Eyepoint LUCIA EYP-1901-302
Offices: Toms River & Edison
A Phase 3, Multicenter, Prospective, Randomized, Double-Masked, Parallel-Group Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Aflibercept in Subjects with Wet AMD
4DMT 4D-150-C003
Offices: Edison & Teaneck
A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration (4FRONT-1)
Artemis ADVM-022-12
Office: Teaneck
A Multi-Center, Randomized, Double-Masked, Active-Comparator-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Ixoberogene soroparvovec (Ixo-vec) in Participants with Neovascular Age-Related Macular Degeneration
Burgundy BP41670
Office: Teaneck
A Three-Part, Phase I/II Study to Investigate the safety, tolerability, pharmacokinetics, and efficacy of zifibancimig following Intravitreal Administration of Multiple Ascending Doses and Continuous Delivery from the Port Delivery in Patients with Neovascular Age-Related Macular Degeneration.
Diabetic Retinopathy
CRIMSON – 1436-0007
Office: Teaneck
A multicenter randomized, sham-controlled (and active controlled in the USA), double-masked, 72-week trial to study the safety, tolerability, pharmacokinetics, and efficacy of 3 dosing regimens of intravitreal BI 764524 in patients with moderately severe to severe non-proliferative diabetic retinopathy
Geographic Atrophy
Astellas Reveal 3021-MA-3543
Offices: Toms River & Edison
A Non-Interventional, Observational Study to Evaluate Treatment Patterns and Safety of Avacincaptad Pegol (ACP/IZERVAY™) in Routine Clinical Practice in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration